Quantcast

Latest Novo Nordisk A/S Stories

2014-09-18 08:29:16

Denmark's Crown Prince Couple Help Celebrate Canadian, Danish Partnership, Marking Novo Nordisk's 30 Years in Canada MISSISSAUGA, ON, Sept. 18, 2014 /CNW/ - Danish-based pharmaceutical company Novo Nordisk, in collaboration with the Royal Danish Consulate General and the Canadian Diabetes Association (CDA), is hosting "Innovation in Diabetes Care: 90 Years and Beyond" at the MaRS Discovery District today, to highlight the significant contribution Canada has made to diabetes care, and...

2014-08-21 12:30:21

DUBLIN, Ireland, August 21, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3zh3q8/global_hormone) has announced the addition of the "Global Hormone Replacement Therapy Market 2014-2018" [http://www.researchandmarkets.com/research/3zh3q8/global_hormone ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Hormone replacement therapy, also known as hormone therapy, is a means of replacing...

2014-07-18 16:23:18

DUBLIN, July 18, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3txjqf/global_type_1) has announced the addition of the "Global Type 1 Diabetes Market 2014-2018" [http://www.researchandmarkets.com/research/3txjqf/global_type_1 ] report to their offering. Type 1 diabetes is an autoimmune disorder characterized by high blood glucose levels. In this condition, the immune system is activated against self-insulin producing cells. This,...

2014-06-04 08:29:58

MISSISSAUGA, ON, June 4, 2014 /CNW/ - Novo Nordisk today announces that the Québec government has approved the inclusion of Victoza(®) (liraglutide), the first once-daily human glucagon-like peptide-1 (GLP-1) analogue, to the Lists of Medications, effective June 2, 2014. The reimbursement of Victoza(®) by the Québec Health Insurance Board (RAMQ) will allow people living with type 2 diabetes to have access to a treatment to help better manage diabetes. Québec is the first...

2014-05-21 08:29:22

DUBLIN, May 21, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/78cbh2/global_pva_drugs) has announced the addition of the "Global PVA Drugs Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Vaginal atrophy is defined as a decrease in estrogen production. Less estrogen leads to thinning, drying, and decreased elasticity of the vaginal tissues. PVA is defined as the decrease in estrogen after menopause. Up to...

2014-03-28 04:21:53

BAGSVAERD, Denmark, March 28, 2014 /PRNewswire/ -- Novo Nordisk today announces the launch of 'Cities Changing Diabetes', an ambitious new partnership programme to fight the urban diabetes challenge. The 'Cities Changing Diabetes' programme will first be launched in Mexico City with other cities in North America, Europe and Asia soon to follow. To view the Multimedia News Release, please click:...

2014-03-11 08:28:29

Patented technology could bring up to $167 million in milestone payments plus future long-term residual royalties to Caisson. OKLAHOMA CITY and AUSTIN, Texas, March 11, 2014 /PRNewswire/ -- Caisson Biotech, L.L.C., a biopharmaceutical company with a patented heparosan-based drug delivery technology, HEPtune(TM), announced today that it has expanded the scope of its partnership with global healthcare leader Novo Nordisk A/S (NYSE: NVO). This latest license agreement gives Novo Nordisk...

2014-02-05 08:29:34

FREMONT, Calif., Feb. 5, 2014 /PRNewswire/ -- Zosano Pharma, Inc. (Zosano) announced today that it has entered into an agreement with Novo Nordisk A/S (NYSE: NVO) to develop a new transdermal presentation of semaglutide, an investigational proprietary human GLP-1 (Glucagon-Like Peptide-1) analogue, to be administered once weekly using Zosano's microneedle patch system for the treatment of type 2 diabetes. Initially, Zosano and Novo Nordisk will engage in collaborative efforts to...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related